Clinical Trials Directory

Trials / Completed

CompletedNCT00047697

Donepezil HCl & Cognitive Deficits in Autism

Donepezil HCl: Treating Cognitive Deficits in Autism

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
8 Years – 17 Years
Healthy volunteers
Not accepted

Summary

This 11-week study will examine the safety and effectiveness of the medication donepezil (Aricept®) compared to placebo for treating cognitive deficits in children and adolescents with Autism Spectrum Disorder.

Detailed description

Children with autism spectrum disorder (ASD) often have impaired communication, problems with social interaction, and repetitive and stereotyped patterns of behavior. While most research has attempted to treat the behavioral deficits commonly associated with ASD, few studies have attempted to improve the core features of this disorder. A recent study found that donepezil HCl helped to improve speech production, attention span, and ability to express emotions in a group of children with autism. This study will provide an opportunity to conduct further testing of the effects of donepezil HCl on the cognitive deficits presumed to underlie the core features of ASD. This study begins at Week 1 with a baseline assessment. Participants are then randomly assigned to either donepezil HCl or placebo. Participants will start with either a 5mg/day dose of donepezil HCl or placebo followed by a cognitive assessment after 4 weeks on this dose. Participants will then have their dose increased to 10mg/day. Another cognitive assessment will be given after 4 weeks on this dose.

Conditions

Interventions

TypeNameDescription
DRUGDonepezil HClParticipants will start with 5 mg per day dose of donepezil HCl, then have their dose increased to 10mg per day after 4 weeks.
DRUGPlaceboPlacebo used in placed of Donepezil HCL

Timeline

Start date
2002-10-01
Primary completion
2006-08-01
Completion
2006-08-01
First posted
2002-10-16
Last updated
2017-10-05
Results posted
2017-10-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00047697. Inclusion in this directory is not an endorsement.